Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Clinical trial NCT00681226 · COMPLETED

Trial details

NCT number: NCT00681226
Sponsor: Bayside Health
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2008-01-01
Primary completion: 2011-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.